investorscraft@gmail.com

Intrinsic ValueMemscap, S.a. (MEMS.PA)

Previous Close4.12
Intrinsic Value
Upside potential
Previous Close
4.12

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

MEMSCAP, S.A. operates in the semiconductor industry, specializing in micro-electro-mechanical systems (MEMS) solutions tailored for aerospace, defense, optical communications, medical, and IT/consumer markets. The company generates revenue through a diversified portfolio of pressure sensors, transducers, and switches, alongside optical MEMS chips and custom manufacturing services. Its products serve critical applications such as air data computers, spinal pressure monitoring, and optical telecommunication networks, positioning MEMSCAP as a niche player in high-precision MEMS technology. The company caters to Fortune 500 firms, research institutions, and universities, leveraging its expertise in MEMS fabrication and prototyping. MEMSCAP’s market position is reinforced by its proprietary multi-user MEMS processes (MUMPs), which offer scalable solutions for industrial and biomedical applications. Despite its specialized focus, the company competes in a broader semiconductor landscape dominated by larger players, relying on innovation and customization to maintain its foothold.

Revenue Profitability And Efficiency

MEMSCAP reported revenue of €12.66 million for the period, with net income of €1.37 million, reflecting a net margin of approximately 10.8%. The company’s operating cash flow stood at €548,000, while capital expenditures were modest at €206,000, indicating disciplined spending. Diluted EPS of €0.18 suggests stable earnings power, though cash flow generation remains relatively constrained compared to net income.

Earnings Power And Capital Efficiency

The company’s earnings are driven by its high-margin MEMS solutions, particularly in aerospace and medical applications. With a beta of 0.858, MEMSCAP exhibits lower volatility than the broader market, aligning with its niche focus. However, capital efficiency is tempered by limited operating cash flow relative to net income, suggesting potential working capital or reinvestment needs.

Balance Sheet And Financial Health

MEMSCAP maintains a balanced financial position, with €3.96 million in cash and equivalents against total debt of €5.05 million. The modest debt level and lack of dividend payouts provide flexibility, though liquidity remains tight given the company’s market capitalization of €27.38 million. The absence of significant capital expenditures underscores a conservative approach to growth funding.

Growth Trends And Dividend Policy

Growth appears steady but unspectacular, with revenue and profitability metrics suggesting incremental progress. The company does not pay dividends, opting to reinvest earnings into its MEMS technology and custom solutions. This aligns with its focus on R&D and niche market expansion, though scalability remains a challenge given its specialized offerings.

Valuation And Market Expectations

At a market cap of €27.38 million, MEMSCAP trades at a P/E multiple of approximately 20x, reflecting investor expectations for sustained profitability in its niche markets. The low beta suggests muted sensitivity to broader market swings, but limited liquidity and small-cap status may deter larger investors.

Strategic Advantages And Outlook

MEMSCAP’s strategic edge lies in its specialized MEMS technology and custom fabrication services, which cater to high-barrier industries like aerospace and medical devices. The outlook hinges on its ability to innovate and scale its proprietary processes, though competition from larger semiconductor firms poses a persistent risk. Near-term growth will likely depend on demand for precision sensors in defense and healthcare applications.

Sources

Company description, financial data provided

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount